Zeuss Review
Best for: Buyers who actively dislike subscription auto-renewals and want a one-time-purchase model for compounded GLP-1 or GIP/GLP-1 — the only provider in the WLR directory offering this billing model. Strong fit for cost-conscious patients who want bundled transparency (provider review + meds + cold-chain shipping + delivery for $125-$175) and the option to order only when needed.
Zeuss (getzeuss.com) is a gender-segmented multi-vertical telehealth platform offering compounded GLP-1 (semaglutide) and GIP/GLP-1 (tirzepatide) for weight loss alongside TRT (men), HRT (women), Skin, and Hair services. DISTINCTIVE NO-SUBSCRIPTION MODEL — verbatim positioning: 'Weight Loss Medications Without the Subscription Traps / Only pay for the care you need — no auto-renewals, no long-term commitments.' Pricing transparency on /services/body-for-him/ and /services/body-for-her/: compounded GLP-1 starting at $125/month; compounded GIP/GLP-1 starting at $175/month — labeled as 'one-time purchase' rather than recurring subscription. Bundled pricing includes 'Licensed provider review + Prescription medication + Cold-chain shipping with temperature-controlled packaging + Delivery to your door' with 'no subscriptions, no memberships, and no hidden fees.' Verbatim FDA disclaimer: 'Compounded medications have not been approved by the FDA. The FDA does not verify the safety, effectiveness, or quality of compounded drugs.' Compounding designation (verbatim): 'Zeuss partners exclusively with 503A and 503B state-licensed compounding pharmacies' — both pathways referenced. 'Full refund issued if a physician can not prescribe treatment.' 'US-licensed physicians.' Specific pharmacy partner names, LegitScript ID, named medical director, full states-served list, corporate legal entity, and governing law are NOT disclosed publicly. Live-verified 2026-05-19 via Chrome MCP (site is JS-rendered SPA — subpaths /body, /weight-loss return 404; actual product pages are at /services/body-for-him/ and /services/body-for-her/).
Medium confidence · Last verified 2026-05-19 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Zeuss is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Zeuss prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Body for Him — GLP-1 | compounded | $125 |
| Body for Her — GLP-1 | compounded | $125 |
| Body for Him — GIP/GLP-1 | compounded | $175 |
| Body for Her — GIP/GLP-1 | compounded | $175 |
✓ Pros
- •**No-subscription / one-time-purchase model is genuinely differentiated** — every other DTC GLP-1 competitor in the WLR directory uses monthly subscriptions with auto-renewal. Zeuss's 'pay only for the care you need' framing is unique.
- •Verbatim FDA compounded-medication disclaimer published — meets WLR transparency standard
- •Both 503A AND 503B compounding pathways explicitly mentioned — uncommon transparency
- •Bundled pricing structure includes everything (provider review + meds + cold-chain shipping + delivery) — no hidden fees framing
- •Full refund if physician cannot prescribe — reduces sign-up risk
- •$125/mo GLP-1 starting price is competitive with the broader DTC market
- •Cold-chain temperature-controlled shipping disclosed (uncommon detail)
- •Gender-segmented Body services accommodate buyers who prefer male-focused or female-focused clinical framing
✗ Cons
- •Specific 503A pharmacy partner NOT named (only generic '503A and 503B state-licensed compounding pharmacies' framing)
- •LegitScript certification NOT mentioned on homepage or Body pages
- •Named medical director / physician leadership NOT disclosed
- •Full states-served list NOT disclosed (only 'US-licensed physicians' generic)
- •Corporate legal entity (LLC/Inc/PC) NOT disclosed in footer
- •Governing law / arbitration venue NOT disclosed
- •Subpath /body, /weight-loss return 404 — actual GLP-1 pages are at /services/body-for-him/ and /services/body-for-her/ (slightly awkward URL structure)
- •Site is JS-rendered SPA — content captured only via Chrome MCP, not WebFetch
- •Specific corporate physical address NOT disclosed in footer
- •$125 / $175 'starting at' framing suggests pricing may step up at higher dose tiers but tier structure not detailed on the public page
Ready to start with Zeuss?
Starting at $125/month. See current pricing and start your free consultation.
Sources & methodology
Our Zeuss review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Zeuss
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Zeuss?
Starting at $125/month. See current pricing and start your free consultation.